{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:27:05Z","timestamp":1788532025964,"version":"build-2803163510"},"reference-count":92,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:p>\n                    Clear cell renal cell carcinoma (ccRCC) is the most common renal carcinoma subtype. Aging-related genes (ARGs) are implicated in ccRCC progression, though their mechanisms remain unclear. This study aimed to elucidate the molecular mechanisms of ARGs in ccRCC and identify potential prognostic biomarkers and therapeutic targets. Transcriptomic data from the cancer genome atlas (TCGA-ccRCC) cohort were analyzed. differentially expressed genes and ARGs were intersected to identify candidate genes. Prognostic ARGs were then screened using machine learning algorithms. A risk model was constructed and validated through survival analysis, stratifying patients into high- and low-risk groups. Functional enrichment, immune infiltration, and drug prediction analyses were performed. The expression levels of prognostic genes in ccRCC tissues were validated through reverse transcription quantitative polymerase chain reaction (RT-qPCR). A total of 2312 differentially expressed genes and 307 ARGs were identified, of which 25 overlapping genes were selected as candidates. Seven ARGs were significantly associated with patient prognosis: protective\n                    <jats:italic toggle=\"yes\">PCK1<\/jats:italic>\n                    , and risk-related\n                    <jats:italic toggle=\"yes\">TOP2A, TFAP2A, CCNA2, FOXM1, CDKN2A<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">PLAU<\/jats:italic>\n                    . High-risk patients showed reduced overall survival rates. Immune infiltration and checkpoint expression differed significantly between risk groups. decision curve analysis indicated high clinical utility. Drug prediction identified 69 potential therapeutic compounds, including tyrosine kinase and mTOR inhibitors. RT-qPCR validated 5 genes\u2019 expression, consistent with bioinformatics predictions, though discrepancies were observed in the expression patterns of\n                    <jats:italic toggle=\"yes\">FOXM1<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic>\n                    . Seven ARGs were identified as key prognostic markers in ccRCC. A robust risk model was established, providing insights into ARG-related mechanisms and potential diagnostic and therapeutic strategies.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048809","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:00:28Z","timestamp":1778896828000},"page":"e48809","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Integrated bioinformatics and experimental validation identify aging-related prognostic genes in clear cell renal cell carcinoma"],"prefix":"10.1097","volume":"105","author":[{"given":"Chen","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibing","family":"Shuang","sequence":"additional","affiliation":[{"name":"Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4931-5842","authenticated-orcid":false,"given":"Ying","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Second Hospital of Shanxi Medical University, Taiyuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260904","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update.","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur Urol"},{"key":"R2-20260904","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants.","volume":"135","author":"Xia","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"R3-20260904","doi-asserted-by":"crossref","first-page":"4832931","DOI":"10.1155\/2017\/4832931","article-title":"miRNAs in prediction of prognosis in clear cell renal cell carcinoma.","volume":"2017","author":"Ran","year":"2017","journal-title":"Biomed Res Int"},{"key":"R4-20260904","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R5-20260904","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.euf.2020.06.024","article-title":"Risk prediction models for kidney cancer: a systematic review.","volume":"7","author":"Harrison","year":"2021","journal-title":"Eur Urol Focus"},{"key":"R6-20260904","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.semcancer.2018.06.004","article-title":"Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): a critical step towards the personalized care of renal cancers.","volume":"55","author":"Li","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"R7-20260904","doi-asserted-by":"crossref","first-page":"719982","DOI":"10.3389\/fmolb.2021.719982","article-title":"Identification of mast cell-based molecular subtypes and a predictive signature in clear cell renal cell carcinoma.","volume":"8","author":"Liu","year":"2021","journal-title":"Front Mol Biosci"},{"key":"R8-20260904","doi-asserted-by":"crossref","first-page":"931383","DOI":"10.3389\/fonc.2022.931383","article-title":"Establishing a prognostic model of ferroptosis- and immune-related signatures in kidney cancer: a study based on TCGA and ICGC databases.","volume":"12","author":"Han","year":"2022","journal-title":"Front Oncol"},{"key":"R9-20260904","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1186\/s12885-021-08559-0","article-title":"A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.","volume":"21","author":"Hong","year":"2021","journal-title":"BMC Cancer"},{"key":"R10-20260904","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12943-024-02020-z","article-title":"Aging and cancer.","volume":"23","author":"Mont\u00e9gut","year":"2024","journal-title":"Mol Cancer"},{"key":"R11-20260904","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/gerona\/glac247","article-title":"The aging-cancer cycle: mechanisms and opportunities for intervention.","volume":"78","author":"Sedrak","year":"2023","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R12-20260904","doi-asserted-by":"crossref","first-page":"13239","DOI":"10.18632\/aging.203008","article-title":"Aging-related genes are potential prognostic biomarkers for patients with gliomas.","volume":"13","author":"Xiao","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"R13-20260904","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41232-022-00197-8","article-title":"The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis?","volume":"42","author":"Ohtani","year":"2022","journal-title":"Inflamm Regen"},{"key":"R14-20260904","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.7150\/ijbs.93598","article-title":"Chk2 modulates bmi1-deficiency-induced renal aging and fibrosis via oxidative stress, DNA damage, and p53\/TGF\u03b21-induced epithelial-mesenchymal transition.","volume":"20","author":"Lu","year":"2024","journal-title":"Int J Biol Sci"},{"key":"R15-20260904","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/CIRCRESAHA.122.321751","article-title":"Accelerated vascular aging in chronic kidney disease: the potential for novel therapies.","volume":"132","author":"Hobson","year":"2023","journal-title":"Circ Res"},{"key":"R16-20260904","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13059-023-02866-4","article-title":"DNA methylation entropy as a measure of stem cell replication and aging.","volume":"24","author":"Vaidya","year":"2023","journal-title":"Genome Biol"},{"key":"R17-20260904","doi-asserted-by":"crossref","first-page":"e010386","DOI":"10.1136\/jitc-2024-010386","article-title":"Stratification system with dual human endogenous retroviruses for predicting immunotherapy efficacy in metastatic clear-cell renal cell carcinoma.","volume":"13","author":"Lu","year":"2025","journal-title":"J ImmunoTher Cancer"},{"key":"R18-20260904","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.3390\/ijms26073125","article-title":"Integrated multi-omics analysis unveils distinct molecular subtypes and a robust immune-metabolic prognostic model in clear cell renal cell carcinoma.","volume":"26","author":"Zhu","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R19-20260904","doi-asserted-by":"crossref","first-page":"2480755","DOI":"10.1080\/07853890.2025.2480755","article-title":"Construction of a novel prognostic model based on lncRNAs-related to DNA damage repair for predicting the prognosis of clear cell renal cell carcinoma.","volume":"57","author":"Chen","year":"2025","journal-title":"Ann Med"},{"key":"R20-20260904","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12575-022-00187-7","article-title":"Comprehensive analysis of cellular senescence-related genes in prognosis, molecular characterization and immunotherapy of hepatocellular carcinoma.","volume":"24","author":"Sun","year":"2022","journal-title":"Biol Proced Online"},{"key":"R21-20260904","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3390\/ijms24021516","article-title":"Identification of aging and young subtypes for predicting colorectal cancer prognosis and immunotherapy responses.","volume":"24","author":"Tan","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R22-20260904","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1038\/s41467-024-49106-2","article-title":"Progressive senescence programs induce intrinsic vulnerability to aging-related female breast cancer.","volume":"15","author":"Bai","year":"2024","journal-title":"Nat Commun"},{"key":"R23-20260904","doi-asserted-by":"crossref","first-page":"871088","DOI":"10.3389\/fgene.2022.871088","article-title":"An aging and senescence-related gene signature for prognosis prediction in clear cell renal cell carcinoma.","volume":"13","author":"Li","year":"2022","journal-title":"Front Genet"},{"key":"R24-20260904","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.3390\/cancers13123045","article-title":"Genome-wide transcriptomic analysis of non-tumorigenic tissues reveals aging-related prognostic markers and drug targets in renal cell carcinoma.","volume":"13","author":"Oh","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R25-20260904","doi-asserted-by":"crossref","first-page":"25980","DOI":"10.18632\/aging.203784","article-title":"Identification of a competing endogenous RNA network related to immune signature in clear cell renal cell carcinoma.","volume":"13","author":"Zhang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"R26-20260904","doi-asserted-by":"crossref","first-page":"21712","DOI":"10.18632\/aging.203514","article-title":"The ceRNA PVT1 inhibits proliferation of ccRCC cells by sponging miR-328-3p to elevate FAM193B expression.","volume":"13","author":"Xie","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"R27-20260904","doi-asserted-by":"crossref","first-page":"D900","DOI":"10.1093\/nar\/gkad927","article-title":"Human ageing genomic resources: updates on key databases in ageing research.","volume":"52","author":"de Magalh\u00e3es","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"R28-20260904","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"R29-20260904","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","article-title":"ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2.","volume":"38","author":"Gustavsson","year":"2022","journal-title":"Bioinformatics"},{"key":"R30-20260904","first-page":"100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"R31-20260904","doi-asserted-by":"crossref","first-page":"3023127","DOI":"10.1155\/2020\/3023127","article-title":"Potential molecular mechanisms of plantain in the treatment of gout and hyperuricemia based on network pharmacology.","volume":"2020","author":"Liu","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"R32-20260904","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/jso.27358","article-title":"Clinicopathological characteristics of pheochromocytoma\/paraganglioma and screening of prognostic markers.","volume":"128","author":"Lei","year":"2023","journal-title":"J Surg Oncol"},{"key":"R33-20260904","doi-asserted-by":"crossref","first-page":"11340","DOI":"10.1038\/s41598-022-15609-5","article-title":"Applying logistic LASSO regression for the diagnosis of atypical Crohn\u2019s disease.","volume":"12","author":"Li","year":"2022","journal-title":"Sci Rep"},{"key":"R34-20260904","doi-asserted-by":"crossref","first-page":"682002","DOI":"10.3389\/fcell.2021.682002","article-title":"Identification of CDK2-related immune forecast model and ceRNA in lung adenocarcinoma, a pan-cancer analysis.","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R35-20260904","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker.","volume":"56","author":"Heagerty","year":"2000","journal-title":"Biometrics"},{"key":"R36-20260904","doi-asserted-by":"crossref","first-page":"2","DOI":"10.18637\/jss.v079.c02","article-title":"plotROC: a tool for plotting ROC curves.","volume":"79","author":"Sachs","year":"2017","journal-title":"J Stat Softw"},{"key":"R37-20260904","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks.","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med"},{"key":"R38-20260904","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"R39-20260904","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/S2215-0366(22)00411-4","article-title":"Correction to Lancet Psych 2022; 9: 938.","volume":"10","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"R40-20260904","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/bioinformatics\/btab806","article-title":"Make interactive complex heatmaps in R.","volume":"38","author":"Gu","year":"2022","journal-title":"Bioinformatics"},{"key":"R41-20260904","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"R42-20260904","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s10147-021-01913-z","article-title":"Aging, cancer, and antitumor immunity.","volume":"27","author":"Ikeda","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"R43-20260904","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.18632\/aging.202589","article-title":"The aging-related risk signature in colorectal cancer.","volume":"13","author":"Yue","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"R44-20260904","doi-asserted-by":"crossref","first-page":"997765","DOI":"10.3389\/fimmu.2022.997765","article-title":"Identification and characterization of aging\/senescence-induced genes in osteosarcoma and predicting clinical prognosis.","volume":"13","author":"Lv","year":"2022","journal-title":"Front Immunol"},{"key":"R45-20260904","doi-asserted-by":"crossref","first-page":"4971345","DOI":"10.1155\/2023\/4971345","article-title":"Eight aging-related genes prognostic signature for cervical cancer.","volume":"2023","author":"Yin","year":"2023","journal-title":"Int J Genomics"},{"key":"R46-20260904","doi-asserted-by":"crossref","first-page":"e36715","DOI":"10.1097\/MD.0000000000036715","article-title":"An aging-related gene signature to predict the prognosis of hepatocellular carcinoma.","volume":"102","author":"Fang","year":"2023","journal-title":"Medicine (Baltim)"},{"key":"R47-20260904","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/CBM-210149","article-title":"E2F1 transcriptionally regulates CCNA2 expression to promote triple negative breast cancer tumorigenicity.","volume":"33","author":"Lu","year":"2022","journal-title":"Cancer Biomark"},{"key":"R48-20260904","doi-asserted-by":"crossref","first-page":"216922","DOI":"10.1016\/j.canlet.2024.216922","article-title":"Smoking-induced CCNA2 expression promotes lung adenocarcinoma tumorigenesis by boosting AT2\/AT2-like cell differentiation.","volume":"592","author":"He","year":"2024","journal-title":"Cancer Lett"},{"key":"R49-20260904","doi-asserted-by":"crossref","first-page":"5910575","DOI":"10.1155\/2022\/5910575","article-title":"CCNA2 as an immunological biomarker encompassing tumor microenvironment and therapeutic response in multiple cancer types.","volume":"2022","author":"Jiang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"R50-20260904","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12935-024-03346-w","article-title":"Assessing the role of programmed cell death signatures and related gene TOP2A in progression and prognostic prediction of clear cell renal cell carcinoma.","volume":"24","author":"Wang","year":"2024","journal-title":"Cancer Cell Int"},{"key":"R51-20260904","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-0-387-69116-9_6","article-title":"The AP-2alpha transcription factor regulates tumor cell migration and apoptosis.","volume":"604","author":"Orso","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"R52-20260904","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41419-023-06090-7","article-title":"The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling.","volume":"14","author":"Shi","year":"2023","journal-title":"Cell Death Dis"},{"key":"R53-20260904","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12935-025-03660-x","article-title":"HNRNPC promotes progression of non-small cell lung cancer by maintaining TFAP2A mRNA stability.","volume":"25","author":"Liao","year":"2025","journal-title":"Cancer Cell Int"},{"key":"R54-20260904","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7150\/jca.37323","article-title":"FOXM1 functions collaboratively with PLAU to promote gastric cancer progression.","volume":"11","author":"Ai","year":"2020","journal-title":"J Cancer"},{"key":"R55-20260904","first-page":"5839","article-title":"Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.","volume":"60","author":"Gutierrez","year":"2000","journal-title":"Cancer Res"},{"key":"R56-20260904","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3892\/or.2022.8462","article-title":"PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer.","volume":"49","author":"Gao","year":"2023","journal-title":"Oncol Rep"},{"key":"R57-20260904","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/cbin.12025","article-title":"PLAU contributes to the development of cholangiocarcinoma via activating NF-\u03baB signaling pathway.","volume":"47","author":"Hu","year":"2023","journal-title":"Cell Biol Int"},{"key":"R58-20260904","doi-asserted-by":"crossref","first-page":"18909","DOI":"10.1038\/s41598-023-46398-0","article-title":"Anoikis-related genes signature development for clear cell renal cell carcinoma prognosis and tumor microenvironment.","volume":"13","author":"Jiang","year":"2023","journal-title":"Sci Rep"},{"key":"R59-20260904","doi-asserted-by":"crossref","first-page":"11474","DOI":"10.18632\/aging.102548","article-title":"Prognostic value of immune-related genes in clear cell renal cell carcinoma.","volume":"11","author":"Wan","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"R60-20260904","doi-asserted-by":"crossref","first-page":"13670","DOI":"10.1038\/s41598-024-64255-6","article-title":"PCK1-mediated glycogenolysis facilitates ROS clearance and chemotherapy resistance in cervical cancer stem cells.","volume":"14","author":"Chen","year":"2024","journal-title":"Sci Rep"},{"key":"R61-20260904","doi-asserted-by":"crossref","first-page":"13102","DOI":"10.1038\/s41598-024-63891-2","article-title":"Identification of subclusters and prognostic genes based on GLS-associated molecular signature in ulcerative colitis.","volume":"14","author":"Xie","year":"2024","journal-title":"Sci Rep"},{"key":"R62-20260904","doi-asserted-by":"crossref","first-page":"559730","DOI":"10.3389\/fonc.2020.559730","article-title":"Dysregulation of long non-coding RNAs and mRNAs in plasma of clear cell renal cell carcinoma patients using microarray and bioinformatic analysis.","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Oncol"},{"key":"R63-20260904","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40170-023-00312-4","article-title":"Restoring gluconeogenesis by TEF inhibited proliferation and promoted apoptosis and immune surveillance in kidney renal clear cell carcinoma.","volume":"11","author":"Zhuang","year":"2023","journal-title":"Cancer Metab"},{"key":"R64-20260904","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1479-5876-10-200","article-title":"Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma.","volume":"10","author":"Xue","year":"2012","journal-title":"J Transl Med"},{"key":"R65-20260904","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4103\/0973-1482.137988","article-title":"Comparison of clinicopathological parameters with FoxM1 expression in renal cell carcinoma.","volume":"10","author":"Kocarslan","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"R66-20260904","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1002\/jcb.28323","article-title":"Homeodomain interacting protein kinase-2 phosphorylates FOXM1 and promotes FOXM1-mediated tumor growth in renal cell carcinoma.","volume":"120","author":"Liu","year":"2019","journal-title":"J Cell Biochem"},{"key":"R67-20260904","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13578-020-00408-0","article-title":"OTUB1-mediated deubiquitination of FOXM1 up-regulates ECT-2 to promote tumor progression in renal cell carcinoma.","volume":"10","author":"Zhou","year":"2020","journal-title":"Cell Biosci"},{"key":"R68-20260904","doi-asserted-by":"crossref","first-page":"e00357","DOI":"10.1128\/MCB.00357-19","article-title":"FOXM1-activated LINC01094 promotes clear cell renal cell carcinoma development via MicroRNA 224-5p\/CHSY1.","volume":"40","author":"Jiang","year":"2020","journal-title":"Mol Cell Biol"},{"key":"R69-20260904","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","article-title":"The cancer genome atlas of renal cell carcinoma: findings and clinical implications.","volume":"16","author":"Linehan","year":"2019","journal-title":"Nat Rev Urol"},{"key":"R70-20260904","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13046-023-02742-w","article-title":"TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma.","volume":"42","author":"Xu","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"R71-20260904","doi-asserted-by":"crossref","first-page":"1225023","DOI":"10.3389\/fimmu.2023.1225023","article-title":"Prognostic and tumor microenvironmental feature of clear cell renal cell carcinoma revealed by m6A and lactylation modification-related genes.","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol"},{"key":"R72-20260904","doi-asserted-by":"crossref","first-page":"8858","DOI":"10.1007\/s00330-023-09869-6","article-title":"A CT-based deep learning radiomics nomogram outperforms the existing prognostic models for outcome prediction in clear cell renal cell carcinoma: a multicenter study.","volume":"33","author":"Nie","year":"2023","journal-title":"Eur Radiol"},{"key":"R73-20260904","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2174\/0929866527666201002150316","article-title":"Transmembrane protein 166 and its significance.","volume":"28","author":"Yang","year":"2021","journal-title":"Protein Pept Lett"},{"key":"R74-20260904","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/jcb.29904","article-title":"Extracellular vesicles and the regulation of tumor immunity: current progress and future directions.","volume":"122","author":"Wang","year":"2021","journal-title":"J Cell Biochem"},{"key":"R75-20260904","doi-asserted-by":"crossref","first-page":"C550","DOI":"10.1152\/ajpcell.00169.2023","article-title":"The SLC38A5\/SNAT5 amino acid transporter: from pathophysiology to pro-cancer roles in the tumor microenvironment.","volume":"325","author":"Taurino","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"key":"R76-20260904","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s13277-015-3999-5","article-title":"The transmembrane transporter ABCC3 participates in liver cancer progression and is a potential biomarker.","volume":"37","author":"Carrasco-Torres","year":"2016","journal-title":"Tumour Biol"},{"key":"R77-20260904","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.3390\/ijms24098093","article-title":"Protein tyrosine phosphatase receptor zeta 1 as a potential target in cancer therapy and diagnosis.","volume":"24","author":"Papadimitriou","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R78-20260904","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00280-020-04218-6","article-title":"The role of the glutamine transporter ASCT2 in antineoplastic therapy.","volume":"87","author":"Teixeira","year":"2021","journal-title":"Cancer Chemother Pharmacol"},{"key":"R79-20260904","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41420-021-00410-6","article-title":"PLAU directs conversion of fibroblasts to inflammatory cancer-associated fibroblasts, promoting esophageal squamous cell carcinoma progression via uPAR\/Akt\/NF-\u03baB\/IL8 pathway.","volume":"7","author":"Fang","year":"2021","journal-title":"Cell Death Discov"},{"key":"R80-20260904","doi-asserted-by":"crossref","first-page":"e59445","DOI":"10.7554\/eLife.59445","article-title":"High-resolution transcriptional and morphogenetic profiling of cells from micropatterned human ESC gastruloid cultures.","volume":"9","author":"Minn","year":"2020","journal-title":"Elife"},{"key":"R81-20260904","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1042\/CS20211180","article-title":"Defining the molecular underpinnings controlling cardiomyocyte proliferation.","volume":"136","author":"Mahiny-Shahmohammady","year":"2022","journal-title":"Clin Sci (Lond)"},{"key":"R82-20260904","doi-asserted-by":"crossref","first-page":"1212476","DOI":"10.3389\/fimmu.2023.1212476","article-title":"Cancer immunotherapies: advances and bottlenecks.","volume":"14","author":"Rui","year":"2023","journal-title":"Front Immunol"},{"key":"R83-20260904","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.3390\/ijms24076849","article-title":"POLD1 as a prognostic biomarker correlated with cell proliferation and immune infiltration in clear cell renal cell carcinoma.","volume":"24","author":"Tian","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R84-20260904","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.3390\/cancers15235530","article-title":"Analysis of the tumor immune microenvironment (TIME) in clear cell renal cell carcinoma (ccRCC) Reveals an M0 macrophage-enriched subtype: an exploration of prognostic and biological characteristics of this immune phenotype.","volume":"15","author":"Farha","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R85-20260904","doi-asserted-by":"crossref","first-page":"20266","DOI":"10.1038\/s41598-023-46577-z","article-title":"Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinoma.","volume":"13","author":"Zhang","year":"2023","journal-title":"Sci Rep"},{"key":"R86-20260904","doi-asserted-by":"crossref","first-page":"1230267","DOI":"10.3389\/fimmu.2023.1230267","article-title":"A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"R87-20260904","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cell.2011.09.028","article-title":"A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA.","volume":"147","author":"Cesana","year":"2011","journal-title":"Cell"},{"key":"R88-20260904","doi-asserted-by":"crossref","first-page":"12156","DOI":"10.1080\/21655979.2022.2073130","article-title":"Role of exosomal competitive endogenous RNA (ceRNA) in diagnosis and treatment of malignant tumors.","volume":"13","author":"Mao","year":"2022","journal-title":"Bioengineered"},{"key":"R89-20260904","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.3390\/cancers13205160","article-title":"MiRNA-424-5p suppresses proliferation, migration, and invasion of clear cell renal cell carcinoma and attenuates expression of O-GlcNAc-transferase.","volume":"13","author":"Kalantzakos","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R90-20260904","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3233\/CBM-200553","article-title":"MicroRNAs MiR-15a and MiR-26a cooperatively regulate O-GlcNAc-transferase to control proliferation in clear cell renal cell carcinoma.","volume":"30","author":"Kalantzakos","year":"2021","journal-title":"Cancer Biomark"},{"key":"R91-20260904","doi-asserted-by":"crossref","first-page":"20220696","DOI":"10.1515\/biol-2022-0696","article-title":"Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features.","volume":"18","author":"Mo","year":"2023","journal-title":"Open Life Sci"},{"key":"R92-20260904","doi-asserted-by":"crossref","first-page":"2325126","DOI":"10.1080\/15384047.2024.2325126","article-title":"TOP2A modulates signaling via the AKT\/mTOR pathway to promote ovarian cancer cell proliferation.","volume":"25","author":"Zhang","year":"2024","journal-title":"Cancer Biol Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:00:56Z","timestamp":1788530456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":92,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048809","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"2025-10-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}